Therapeutic Solutions International announced the launching of the Veltmeyer Institute for Advanced Biologics. The organization is focused on providing patients access to JadiCell adult stem cells in the field of brain and lung conditions under the Right to Try Law in applicable cases. The Veltmeyer Institute is believed to be the only organization providing allogeneic stem cells that have been cleared by the FDA for clinical trials.

The Veltmeyer Institute leverages the experience of Dr. James Veltmeyer who has treated over 100 patients under the Right to Try Law in collaboration with Therapeutic Solutions International and other Biotechnology Companies.